Botulinum Toxin A Single Blind Split-Face Randomized Pilot Study

Inclusion Criteria: * Female subjects between ages of 35 to 65 years (inclusive) who exhibit static wrinkles in the following areas: glabella (forehead frowns), periorbital area (crows feet). Static wrinkles in additional areas of the face are also acceptable. * Subject is willing to maintain the same skin care regimen throughout the study and has already maintained this skin care regime for 4 weeks prior to baseline. * The subject is able to comply with study procedures and instructions and is committed to attend all study visits within the given timelines. * Subject is judged to be a good candidate by study nurse upon identification of dynamic and/or static wrinkles in the areas of movement, and with a moderate amount of skin laxity. * Subject is willing to use contraception * A signed informed consent form by a subject able to give consent, prior to any study procedures are performed. Exclusion Criteria: * Sensitivity and/or contraindications to botulinum toxin A other ingredients contained in the botulinum toxin A products. * Any medical condition, in the opinion of the investigator, that would interfere with safety or any study procedures (e.g. auto-immune disease, history of severe allergies, hypertrophic scars, immunotherapeutic treatment, inflammatory or infectious complaints at injection sites, unable to give consent) * Treatment with botulinum toxin A injections in the neck or face within 1 year of baseline treatment * Treatment with facial fillers less than 1 ye…